UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 15.388

Sortiert nach

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma

British journal of cancer, 2021-02, Vol.124 (4), p.744-753

2021

Volltextzugriff (PDF)

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Cancer discovery, 2018-11, Vol.8 (11), p.1404-1421

2018

Volltextzugriff (PDF)

The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Clinical cancer research, 2019-10, Vol.25 (20), p.6127-6140

2019

Volltextzugriff (PDF)

Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.415-424

2008

Volltextzugriff (PDF)

Synthesis and characterization of homogeneously sulfonated poly(ether ether ketone) membranes: Effect of casting solvent

Journal of applied polymer science, 2008-11, Vol.110 (3), p.1763-1770

2008

Volltextzugriff (PDF)

MatchMiner: an open-source platform for cancer precision medicine

NPJ precision oncology, 2022-10, Vol.6 (1), p.69-69, Article 69

2022

Volltextzugriff (PDF)

Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Clinical cancer research, 2021-09, Vol.27 (17), p.4710-4716

2021

Volltextzugriff (PDF)

Stress-specific signatures: expression profiling of p53 wild-type and -null human cells

Oncogene, 2005-06, Vol.24 (28), p.4572-4579

2005

Volltextzugriff (PDF)

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)

Journal of clinical oncology, 2017-05, Vol.35 (14), p.1561-1569

2017

Volltextzugriff (PDF)

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1

Clinical cancer research, 2019-10, Vol.25 (19), p.5808-5817

2019

Volltextzugriff (PDF)

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Gynecologic oncology, 2020-10, Vol.159 (1), p.150-156

2020

Volltextzugriff (PDF)

Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

Clinical cancer research, 2021-07, Vol.27 (14), p.3845-3853

2021

Volltextzugriff (PDF)

Immune modulating activity of the CHK1 inhibitor prexasertib and anti-PD-L1 antibody LY3300054 in patients with high-grade serous ovarian cancer and other solid tumors

Cancer Immunology, Immunotherapy, 2021-10, Vol.70 (10), p.2991-3000

2021

Volltextzugriff (PDF)

First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.925-e1918

2021

Volltextzugriff (PDF)

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

Clinical cancer research, 2022-01, Vol.28 (2), p.279-288

2022

Volltextzugriff (PDF)

A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid Tumors

Clinical cancer research, 2020-11, Vol.26 (21), p.5588-5597

2020

Volltextzugriff (PDF)

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2020-12, Vol.86 (6), p.815-827

2020

Volltextzugriff (PDF)

Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)

JCO precision oncology, 2021, Vol.5

2021

Volltextzugriff (PDF)

Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation

Radiation research, 2000-09, Vol.154 (3), p.342-346

2000

Volltextzugriff (PDF)

Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1577-1586

2021

Volltextzugriff (PDF)

Clinical Efficacy of Olaparib in IDH1/IDH2- Mutant Mesenchymal Sarcomas

JCO precision oncology, 2021-11, Vol.5, p.466

2021

Volltextzugriff (PDF)

Abstract 3157: Serial droplet digital PCR (ddPCR) of plasma cell-free DNA (cfDNA) as pharmacodynamic (PD) biomarker in Phase 1 clinical trials for patients (pts) with KRAS mutant non-small cell lung cancer (NSCLC)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3157-3157

2016

Volltextzugriff (PDF)

Induction of stress genes by low doses of gamma rays

Radiation research, 1999-09, Vol.152 (3), p.225

1999

Volltextzugriff (PDF)

Comparison of homogeneously and heterogeneously sulfonated polyetheretherketone membranes in preparation, properties and cell performance

Journal of power sources, 2008-10, Vol.185 (1), p.63-69

2008

Volltextzugriff (PDF)

1 – 25 von 15.388

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.428)
Mit Volltextzugriff
(14.205)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(7.631)
Life Sciences & Biomedicine
(3.489)
Technology
(3.140)
Physical Sciences
(2.047)
Humans
(1.786)
Engineering
(1.379)
Computer Science
(1.335)
Chemistry
(969)
Male
(893)
Female
(868)
Engineering, Electrical & Electronic
(680)
Materials Science
(662)
Vietnam
(657)
Computer Science, Theory & Methods
(645)
Physics
(633)
Science & Technology - Other Topics
(615)
Computer Science, Information Systems
(602)
Social Sciences
(571)
Animals
(549)
Adult
(486)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(5.914)
EZB Electronic Journals Library
(5.507)
IngentaConnect Journals
(2.844)
MEDLINE
(2.454)
Publisher or Other Site
(2.030)
Access via ScienceDirect (Elsevier)
(1.966)
Ebook Central Perpetual and DDA
(1.654)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.617)
eBooks on EBSCOhost
(1.562)
IEEE Xplore
(1.396)
Business Source Ultimate
(1.309)
Nexis Uni (LexisNexis)
(1.180)
Springer Journals
(1.105)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.086)
Wiley Online Library
(1.009)
Wiley Online Library
(686)
SpringerLink Series
(678)
EZB-NALI2-00462 Springer Archive NL
(651)
Access via Taylor & Francis
(403)
Taylor & Francis Current Content Access
(371)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Wwd
(1.069)
E3s Web Of Conferences
(481)
Plos One
(164)
Rsc Advances
(75)
The Journal Of Asian Finance, Economics, And Business
(66)
Scientific Reports
(61)
Diagnostic Cytopathology
(56)
Ieee Access
(51)
Gastroenterology
(49)
Journal Of The American College Of Cardiology
(49)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt